Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 50 Life Science Startup Investors in China

Last updated: Apr 2024 A list of 50 angel investors and VC funds that invest in Life science startups based in China. We rank investors based on the number of investments they made in Life science companies from China. We update this investor list every month.

Top 50 Life Science Startup Investors in China

Investor	Life Science China investments
Sequoia Capital China	5
Hillhouse Investment	5
Prox Ventures	4
Qiming Venture Partners	4
EFung Capital	4
Huagai Capital	4
WuXi AppTec	3
BioVenture	3
Legend Capital	3
Entrepreneurship Relay Group	3
ULTIMA	3
Loyal Valley Capital	2
Huimei Capital	2
Zoo Capital	2
MiraclePlus	2
ASBV	2
Med-Fine Capital	2
CD Capital	2
Orient Securities Capital Investment	2
Sherpa Venture Capital	2
Green Pine Capital Partners	2
Lilly Asia Ventures	2
Eight Roads Ventures	2
Bits x Bites	2
Oriental Fortune Capital	2
Gaw Capital Partners	2
BOHE Angel Fund	2
Lucion	2
CentreGold Capital	2
Highlight Capital	2
Mega Technology	1
Sinovation Ventures	1
Yuanhe Holding	1
N5Capital	1
Hefei Industry Investment Group	1
Boyu Capital	1
Chengdu Kanghua Biological Products	1
Zhengxuan Investment	1
NewMargin Ventures	1
Sunz Fund	1
Hongfeng Investment Management	1
Wanwu Capital	1
Zhejiang Synergy	1
Frees Fund	1
Yingmeng Capital	1
Nanjing Fuze	1
Alibaba Group	1
Shengshan Capital	1
Kaitai Capital	1
Gong Hongjia	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

We help founders build enduring companies.

Investment focus

Biotechnology, Health Care, Software
Series A, Series B, Series C
China, United States, Australia

Portfolio highlights

Black Jade Star Rock — Black Jade Star Rock develops organoid-based intelligent equipment and chips. It is a biomedical research and development company with organoid science as its fundamental technology.
Moonshot AI — Dark Side of the Moon is an AI large-scale model company.
Membrane Biofilm Technology — Membrane Biofilm Technology is a membrane filtration company that specializes in the development, production, and solutions of membrane filtration products.

Hillhouse Capital Group is an investment management firm that invests with a long-term time horizon. Hillhouse owns companies across equity stages, spanning the range from new start-ups to the world’s most established public companies. It may invest in a company as a start-up and continue to hold it in the portfolio as a public equity investment.This stage-agnostic investment style allows them to focus on multi-year results, rather than on quarterly earnings.Hillhouse Capital Group invests globally, with a particular focus on Asia. Independent, proprietary research lies at the heart of our investment process. Our team members are sector experts in consumer, Internet, media, and healthcare. Hillhouse Capital Group was founded in 2005 and is based in Beijing, China.

Investment focus

Biotechnology, Health Care, Software
Series B, Series A, Series C
China, United States, India

Portfolio highlights

Tenways — TENWAYS Electric Bikes with multi-scenario applications for superior value, light weight, quick charge and instant assistance. For commuting, lifestyle, exercising and more.
Xingmai Innovation — Xingmai Innovation creates, develops, and sells intelligent swimming pool cleaning robots.
Deep Vision Intelligence — Deep Vision Intelligence is a developer of embedded machine vision products.

Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.

Investment focus

Medical, Biotechnology, Health Care
Funding Round, Seed, Series A
China, United States, United Kingdom

Portfolio highlights

VerImmune — Located in Baltimore, Maryland, VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection. This strategy utilizes a proprietary tumor-specific, tumor type agnostic, virus-inspired platform termed Anti-tumor Immune Redirection Virus-inspired Particles (AIR-ViPs) that redirectspre-existing pathogenic or childhood vaccine immune memory towards tumors.
Zhenyi Yiliao — Zhenyi Yiliao is a medical enterprise focusing on structural heart disease.
Rhino Medical — Rhino Medical develops advanced technologies with independent intellectual property rights. The founding team has rich experience in R&D, marketing, and clinical. On the basis of benchmarking imported phacoemulsification instruments and vitrectomy instruments

Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.

Investment focus

Health Care, Biotechnology, Medical
Series B, Series A, Series C
China, United States, Hong Kong

Portfolio highlights

Ruining Bio — Ruining Bio provides clinical medical solutions such as tumor radiotherapy protection, wound repair, tumor embolization, and anti-tumor drugs. Ruining Bio brings together various professionals in materials, chemistry, biomedical engineering, and clinical medicine.
Hope Medicine — Hope Medicine is committed to researching, developing and commercializing the first innovative drugs aimed at improving the quality of life for a wide range of popular male and female diseases.
Silicon Yi Technology — Silicon Yi Technology is an RNA nano-pesticide research and development firm.

Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VCInstitutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion.

Investment focus

Biotechnology, Health Care, Pharmaceutical
Series A, Series B, Series C
China, United States, India

Portfolio highlights

Turno — Turno Finance makes owning EV very affordable. Turno Club is a community around commercial EVs. Turno Battery Future is our solution to keeping batteries on the road for longer.
Pregis New Materials — Pregis New Materials is a cold chain technology company that provides customers with dual carbon and temperature control solutions and materials.
Huayuan Regenerative Medicine — Huayuan Regenerative Medicine is a developer of implantable biological artificial organs.

Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Angel
China, United States, Hong Kong

Portfolio highlights

Leo Summit — Leo Summit is positioned as a provider of life science laboratory automation solutions. It provides reliable and flexible solutions for the biomedical industry, driven by the demand for automated intelligent technology in clinical medicine and drug R&D industries, and relies on artificial intelligence and motion control technology. Providesystematic intelligent products and solutions for R&D firms, AI pharmaceuticals, and CRO firms in the fields of new medications, synthetic biology, and single-cell sequencing.
Bluesail Surgical — Bluesail Surgical is a surgical device company that specializes in the development of innovative surgical instruments for cardiovascular and cerebrovascular treatments.
Bowang Pharmaceutical — Bowang Pharmaceutical is an RNAi drug research and development platform focused on siRNA drug development.

WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. As an innovation-driven and customer-focused company, WuXi AppTec helps our partners improve theproductivity of advancing healthcare products through cost-effective and efficient solutions,With industry-leading capabilities such as R&D and manufacturing for small molecule drugs, cell and gene therapies, and testing for medical devices, WuXi AppTec's open-access platform is enabling more than 3,900 collaborators from over 30 countries to improve the health of those in need – and to realize our vision that "every drug can be made and every disease can be treated".

Investment focus

Biotechnology, Pharmaceutical, Health Care
Series A, Series B, Series C
United States, China, Israel

Portfolio highlights

D3 Bio — D3 Bio is a globally focused biotechnology company focusing on developing and registration of innovative medicines in oncology and immunology. At D3 Bio, our new medicine development approach is fundamentally differentiated. We do not just only start with science in the lab. First, we pinpoint the greatest unmet patient and market needs – whereexisting standard-of-care approaches yield unsatisfactory clinical outcomes. Then we take those insights into the lab to guide the identification of fit for purpose science and technology and define our drug development path.
ShouTi — ShouTi specializes in the discovery and development of drugs against a type of targets called GPCR. The company develops drugs focused on novel small molecules for multiple unmet medical needs. ShouTi is currently operating in Stealth mode.
Bioyond Tech — Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.

Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.

Investment focus

Health Care, Medical, Biotechnology
Series A, Series B, Seed
China, United States, Taiwan

Portfolio highlights

Secretech — Secretech is a R&D-driven biotechnology company.Secretechis creates biomarkers and cellular exosomes and is dedicated to the discovery and development of novel biomarkers and cellular exosomes.
Gachun Biotech — Gachun Biotech is a pharmaceutical intermediates industrialization platform that focuses on APIs, or pharmaceutical intermediates.
Changsha Morning Shine — Changsha Morning Shine is an innovative pharmaceutical company that specializes in R&D outsourcing, biomedicine, chemical drugs, and biotechnology services.

Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.

Investment focus

Health Care, Medical, Biotechnology
Series B, Series A, Series C
China, United States, South Korea

Portfolio highlights

MS Energy — MS Energy is a technology-driven enterprise that specializes in providing green energy solutions.
Dearer Medical — Dearer Medical is a medical device company that specializes in the development, production, and sales of eye-related medical products such as color contact lenses.
Zhongke Guosheng — Zhongke Guosheng is a bio-based materials R&D firm that designs and develops furan-based bio-based materials.

Entrepreneurship Relay Group manages a fund of more than 4 billion yuan, directly or indirectly.

Investment focus

Medical, Life Science, Biotechnology
Series A, Angel, Series C
China

Portfolio highlights

Bangqi Biological — Bangqi Biological is a biotechnology company that focuses on the research and development, production, registration, quality, supply chain and sales of instruments and reagents for autoimmunity & allergy diagnosis.
Shanghai Bioprofile — Shanghai Bioprofile is a metabonomics technology service provider.
Lingyun Microelectronics — Lingyun Microelectronics is a manufacturer of high-speed digital-analog hybrid interfaces and control processors.

ULTIMA is an investment management firm.

Investment focus

Hardware, Software, Agriculture
Angel, Series A
China

Portfolio highlights

Maimai — Maimai provides software and hardware smart care solutions for middle-to-high-end institutions, senior citizens, communities and home care.
Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.

Loyal Valley Capital is a thematic, research-driven private equity firm.

Investment focus

Biotechnology, Health Care, Pharmaceutical
Series C, Series B, Series A
China, United States, Hong Kong

Portfolio highlights

Chabaidao — Chabaidao is a tea drink brand that aims to create surprises through product development and trendy gameplay.
DP Technology — Deep Technology uses a new generation of molecular simulation technology to tackle micro-scale industrial design difficulties. Founded in 2018 and is based in Beijing China.
Core Medical Technology — Core Medical Technology is a technology enterprise mainly engaged in the research, production, development, and sales of implantable left ventricular assist devices, extracorporeal ventricular assist devices, percutaneous interventional ventricular assist devices, and equipment. The company was founded in 2016 and is based in Shenzhen, China.

Huimei Capital primarily seeks investment in the medical and healthcare ecosystem in a multi-dimensional and three-dimensional manner. It is committed to building a professional investment platform with international vision and local execution, helping early and growing medical and health companies to grow rapidly.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
China, United States, Japan

Portfolio highlights

Sensview — Sensview specializes in the development and production of solid-state imaging chips and detector modules.
Xushui Internet — Xushui Internet provides image equipment monitoring, operation, and maintenance cloud services, large-scale equipment IoT management system, digital integration services for hospital-wide equipment, and remote collaborative image inspection system.
Zilixir Biotech — Zilixir Biotech develops a new protein design technology that offers possibilities for human exploration of the complex life sciences. SWORD™ protein design technology integrates binding pockets, new drug skeleton design, activity prediction, ADME/T prediction, etc., and has had some achievements in these areas, fully demonstrating theeffectiveness of protein design.

Zoo Capital is focusing on early-stage investments in technology, healthcare, and consumer companies.

Investment focus

Artificial Intelligence, Software, Biotechnology
Seed, Series A, Series B
China, Hong Kong, United States

Portfolio highlights

TabbyML — LLM x DevTools + OpenSource
Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
Xingan Technology — Xingan Technology is a developer of SiC power semiconductor products.

MiraclePlus invests in and accelerates early-stage startups. MiraclePlus assists startups in developing products that are good enough to succeed in the market. MiraclePlus' acceleration program works with the founders to get each team in top shape so that they can present to thousands of investors on Demo Day.

Investment focus

Artificial Intelligence, Software, Information Technology
Seed, Angel, Pre-Seed
China, United States, Singapore

Portfolio highlights

Kanaries — Kanaries is a company in automated data science that specializes in enhanced analytical data services. Its solutions include the RATH intelligent data analysis platform and the pygwalker open source data visualization tool, among others, which use AI, causal inference, and an intelligent visualization engine for aid.
Chipfy Technology — Chipfy Technology is an integrated circuit design network solutions company that focuses on providing chip IP design services for high-speed interfaces.
RWKV Yuanshi Intelligence — RWKV Yuanshi Intelligence is a domestic open source provider of huge language models with non-Transformer architecture. Its solutions combine the benefits of Transformer and RNN: high and consistent inference efficiency, low and consistent graphics memory utilization, support for unbounded context, and chip compatibility.

ASBV focuses on early and mid-term venture capital investments.

Investment focus

Health Care, Medical, Service Industry
Series A, Seed, Angel
China

Portfolio highlights

Boundary Intelligent Control — Boundary Intelligent is specialized in creating airborne systems, such as flight control systems, that satisfy the needs of civil aircraft, as well as enhancing the ecology of the civil aviation industry and constructing aircraft perception, navigation, decision-making, and planning capabilities.
Huasaiboman Medical Cell Biology — Warseeberman is a cell therapy solution provider, focusing on new cell therapy technologies, based on clinical research, and dedicated to the development of immune cell drug products for the treatment of solid tumors and stem cell therapy products for the treatment of degenerative diseases. The company aims at the cutting-edge technology of tumorimmunotherapy, focuses on the development of tumor infiltrating lymphocyte (TIL) drugs for solid tumors, and cooperates with many hospitals to establish a solid tumor and clinical transformation research institute, dedicated to bringing life to solid tumor patients Hope.
Longyue Mechanical and Electrical Technology — Longyue Mechanical and Electrical Technology engaged in technologies, strengthened linkages, and provided commercial aircraft services.

Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Seed
China, United States

Portfolio highlights

Med-Vision — Virtual reality (VR) medical care service provider based in Hangzhou.
Rebbeca Med — Rebecca is committed to the application of precision-controlled MEMS radio frequency technology in clinical disease control and rehabilitation. Its core technology comes from the core team's many years of experience and achievements in research and development and productization at the University of California, Fortune 500 medical equipment,and electronic equipment companies. The company cooperated with domestic university research institutes and many top three hospitals in Beijing, Shanghai, and Hangzhou to independently develop micro-radio frequency technology that surpassed similar products in Europe and America. It focuses on delivering innovative medical solutions to the hands of professional caregivers. Rebecca's team possesses technical expertise in micro-devices, RF, and device integration through years of field practice in micro-electronics and clinical innovation.
Leadinno Medical Valley — Leadino Medical Valley is a producer of medical devices for neuroregulatory functions.

CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors.

Investment focus

Health Care, Biotechnology, Medical Device
Series A, Series B, Angel
China, United States

Portfolio highlights

Kanova — Kanova is a biopharmaceutical firm.
Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
Greenon Biotech — Greenon Biotech specializes in the research, development, production, and promotion of alternative antibiotic preparations for animals, which primarily include bacteriophages, probiotics, plant extracts, novel acid preparations, high-efficiency disinfectants, and so on.

Orient Securities Capital Investment is an private equity fund business platform.

Investment focus

Health Care, Manufacturing, Software
Series A, Series D, Series C
China

Portfolio highlights

News Dart — News Dart is a manufacturer of precision planetary reducers and helps promote automation and intelligence transmission solutions.
HiStarlink — HiStarlink is a commercial company that makes communication technology like space-borne laser communication terminals and core devices. The main product matrix covers aerospace Advanced core optoelectronic devices, ultra-high-speed communication algorithms, laser communication terminals, and satellite-to-ground laser ground receiving systems.
Shiyu Precision — Shiyu Precision is a high-tech enterprise specializing in the research, development and manufacture of semiconductor automation equipment.

Sherpa Venture Capital is an investment firm that focuses on the investment and cultivation of the Pharmaceutical and Biotech industry. It also specializes in the investment and management of sector leaders and innovators within the Pharma, GeneTech, MedTech, Medical services, and various sub-sectors, where they have established robust portfoliosources, lasting value-adding cooperations and relationships, as well as mature all-cycle services with key resources. It was founded in 2018 and is headquartered in Beijing, China.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
China, United States, Kenya

Portfolio highlights

Alamar Biosciences — Next-gen proteomic platform with ultra-high sensitivity and multiplexing capability for plasma protein detection and liquid biopsies.
New Vision Medical — New Vision Medical is an IT infrastructure service provider that offers clinical trial-related digital platforms and services.
Leadsynbio — Pilot Bio is a bio-manufacturing technology research and development company, focusing on bio-manufacturing of major chemical products, bio-process substitution in heavy-polluting industries, etc., providing users with bio-catalytic synthesis processes, enzyme product research and development, production, sales, and downstream companies with enzymeengineering , Technical service outsourcing and production service outsourcing of strain transformation and metabolic engineering.

Green Pine Capital Partners is a venture capital firm.

Investment focus

Artificial Intelligence, Manufacturing, Software
Series A, Angel, Series B
China, United States, Canada

Portfolio highlights

Biodep — Biodep produces probiotics and derivatives, which are used in meals, healthy foods, cosmetics, environmental remediation, contemporary agriculture, and other industries.
Baisios — Baisios is a developer of tumor immune cell therapy technology and is dedicated to the growth of the tumor biotherapy industry.
Guorui Xiechuang — Guorui Xiechuang is a joint venture subsidiary of Betterray New Materials Group Co., Ltd., provides power + energy storage products and system integration solutions for global customers.

Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
China, United States, Hong Kong

Portfolio highlights

ProfoundBio — ProfoundBio is an oncology biotherapeutics company focused on the development of novel antibody-based therapeutics with curative potential for patients with cancer.
Targeting One — Targeting One is an in-vitro diagnostic product developer.
Comanche Biopharma — Comanche Biopharma is a biopharmaceutical company that develops siRNA therapy for the treatment of preeclampsia. The company aims to lower the risks of pregnancy and prematurity by safely sustaining natural pregnancy and allowing fetal maturation.

Eight Roads has a 50+ year history of investing and partners with game-changing technology and healthcare companies, supporting them as they scale to become global leaders.

Investment focus

Software, Health Care, Information Technology
Series B, Series A, Series C
United States, China, India

Portfolio highlights

HiLabs — A Monetizable Artificial Intelligence Platform
EurekaBio — EurekaBio is a leading upstream core vendor in the field of Cell and Gene Therapy (CGT), focusing on innovative research and development of cutting-edge technologies and key equipment essential for advancing CGT.
Shadowfax — Best last mile delivery service provider across Food, E-commerce, Groceries, Pharma, FMCG, Consumer durables, Auto, BFSI, Telecom, Freight forwarding & Apparel.

Bits x Bites is a food tech VC that invests in early-stage startups tackling global food system challenges. It targets companies innovating across the food supply chain, from farming, production, distribution, and logistics, to consumer goods and food services.

Investment focus

Biotechnology, Food and Beverage, Food Processing
Series A, Seed, Series B
China, Israel, Singapore

Portfolio highlights

Ketai Bio — Ketai Bio is a synthetic biology company dedicated to the R&D, production and sales of high value-added bio-based products.
Mojia Bioscience — Mojia Bioscience is a biotechnology company.
Changjin Biotechnology — Changjin Biotechnology engages in the research, development, and industrialization of microbial synthetic proteins.

Shenzhen Oriental Fortune Capital Co Ltd. is a venture capital firm specializing investment in early venture, mid venture, late venture, emerging growth, Pre-IPO, mature, growth capital stage, mezzanine and new third board investments. The firm typically invests in financial services, telecommunication, new energy, consumer goods, medical treatmentand healthcare, life sciences, internet plus healthy lifestyle industry, logistics, energy technology, information technology, mobile innovation, media, movies and television, culture, pharmaceutical, biological medicine, renewable energy, retail, environmental protection business, consumption, new materials, new agriculture, advanced manufacturing, equipment manufacturing, culture, entertainment, and services. It seeks to invest in China focusing on Shenzhen, Shanghai, Beijing, Xi’an, and Wuhu. The firm also invests in Pearl River Delta region, Yangtze River Delta region, and Circum-Bohai-Sea region. For Pearl River Delta, it covers Guangzhou, Shenzhen, Foshan, Dongguan, Zhongshan, Zhuhai, Huizhou, Jiangmen, and Zhaoqing cities in China. For Yangtze River Delta, the firm covers Shanghai, Nanjing, Wuxi, Changzhou, Suzhou, Nantong, Yancheng, Yangzhou, Zhenjiang, Taizhou, Hangzhou, Ningbo, Jiaxing, Huzhou, Shaoxing, Jinhua, Zhoushan, Taizhou, Hefei, Wuhu, Ma’anshan, Tongling, Anqing, Chuzhou, Chizhou, and Xuancheng cities in China. For the Circum-Bohai-Sea region, it covers Beijing, Tianjin, Shenyang, Dalian, Qingdao, Dandong, Yingkou, Panjin, Fuxin, Huludao, Chaoyang, Shijiazhuang, Baoding, Tangshan, Qinhuangdao, Cangzhou, Langfang, Chengde, Zhangjiakou, Handan, Xingtai, Dongying, Yantai, Weifang, Weihai, Rizhao, and Binzhou cities in China. The firm prefers to invest 20% of its portfolio to early stage, 40% to expansion stage, and 40% to Pre-IPO stage. Shenzhen Oriental Fortune Capital Co Ltd. was formed in November 2007 and is based in Shenzhen, China with offices in Shanghai, China; Beijing, China; and Wuhu, China.

Investment focus

Software, Information Technology, Manufacturing
Series A, Series B, Seed
China, United States

Portfolio highlights

Renshuo Solar — Renshuo Solar is a manufacturer of perovskite tandem solar panels.
Leen Automation — Leen Automation is an automation technology company that focuses on the development and manufacturing of servo drives and motors.
Yihua New Energy — Yihua New Energy manufactures bipolar sodium-ion batteries designed based on low-cost solid electrolyte materials.

Gaw Capital Partners is a positioned private equity fund management company that focuses in real estate markets in greater China and other high barrier-to-entry markets globally. Their services includes gateway real estate funds, separate account investments, venture capital, private equity investment and credit investments.

Investment focus

Information Technology, Hotel, Property Management
Series A, Seed, Series B
China, Singapore, United States

Portfolio highlights

Blackpanda — Asia's premier digital forensics and cyber incident response firm.
Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
Gusto Collective — First brandtech group using the latest technology to help brands create content and experiences across the physical and virtual worlds.

BOHE Angel Fund is an investment Fund.

Investment focus

Health Care, Medical, Biotechnology
Angel, Seed, Series A
China

Portfolio highlights

Levostar — Levostar is a biotechnology company that specializes in the development and manufacture of cell and gene therapy products.
Singlomics — Singlomics uses single-cell sequencing technology to develop antibody drugs for the treatment of infectious diseases and cancers.
Shuimu BioSciences — Shuimu BioSciences Ltd. was founded in 2017 in Beijing, China, to bring the power of Cryo-EM to new therapeutics developers through a differentiated service offering, making the method accessible and affordable for Discovery teams at all stages of method adoption. We are the first commercial full service Cryo-EM platform in Asia, led by top expertsfrom Tsinghua University and experienced industry executives. All of our work is performed with the quality controls and service levels expected of a top tier contract research organization.

Lucion is an influential professional venture capital institute.

Investment focus

Biotechnology, Manufacturing, Medical
Series A, Series B, Seed
China

Portfolio highlights

Keylights — Keylights focuses on the research and development, production, and sales of in vitro diagnostic instruments, it supplies domestic and international consumers with ultra-stable, high-performance, and cost-effective goods and CDMO services.
Runfu Power — Runfu Power is a planetary roller screw R&D manufacturer, committed to the development and production of planetary roller screws.
ThunderBio Innovation — ThunderBio Innovation engages in business includes tumor screening based on the digital biopsy technology of microfluidic chip, etc.

Our team invests in early-stage digital health and consumer startups at CentreGold Capital.

Investment focus

Medical Device, Artificial Intelligence, Internet
Seed, Series A, Angel
United States, China, Canada

Portfolio highlights

Juix — Juix is a power bank rental service that allows people to charge their devices on the go.
Virgo Surgical Video Solutions — Accelerate GI clinical trials with AI for endoscopy. Use video to automate workflows, improve standard of care, and accelerate results.
WeBox — Saltalk is a virtual kitchen platform that focuses on Asian Authentic Food optimized for delivery services.

They are an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect in China and to partner with entrepreneurs with dedication and the highest standard.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Series C
China, United States, Portugal

Portfolio highlights

EdgeRock — EdgeRock offers an automotive integrated brake-by-wire system. EdgeRock supplies highly integrated capabilities for big and heavy load technologies.
Hydropeng Technology — Hydropeng Technology is a company that developes solid oxide fuel cell specializes in the engineering development of solid oxide fuel cells (SOFC) and electrolytic cells (SOEC). Hydropeng Technology applies its extensive R&D capabilities in materials, chemistry, mechanics, and other fields to create efficient hydrogen energy systems thatfulfill the green energy demands of global ESG development.
Shifan Microelectronics — Shifan Microelectronics offers intelligent display SOC chip design and development services. Shifan Microelectronics is primarily concerned with the research and development of display processing and device technologies.

Mega technology is a technology firm that specializes in superior productivity technologies. It is dedicated to strengthening the domains of life science, clinical diagnosis, applied chemistry, and advanced manufacturing through the deep integration of robotic automation, artificial intelligence technology, and industry applications.

Investment focus

Portfolio highlights

Magair Chemical — Magair Chemical is a chemical synthesis CRO that was founded by Magera Technology. It is committed to using automated and intelligent platforms to provide new drug R&D customers with a new generation of chemical synthesis CRO services, significantly shortening the delivery of chemical synthesis links in the new drug R&D cycle, andsignificantly reducing the costs associated with chemical synthesis, removing pharmaceutical synthesis's current reliance on manual operations.

Sinovation Ventures is a full-service venture capital firm that actively invests in the Chinese technology market.

Investment focus

Software, Artificial Intelligence, Internet
Series A, Seed, Series B
China, United States, Singapore

Portfolio highlights

Hope Medicine — Hope Medicine is committed to researching, developing and commercializing the first innovative drugs aimed at improving the quality of life for a wide range of popular male and female diseases.
Magair Chemical — Magair Chemical is a chemical synthesis CRO that was founded by Magera Technology. It is committed to using automated and intelligent platforms to provide new drug R&D customers with a new generation of chemical synthesis CRO services, significantly shortening the delivery of chemical synthesis links in the new drug R&D cycle, andsignificantly reducing the costs associated with chemical synthesis, removing pharmaceutical synthesis's current reliance on manual operations.
Heranova Lifesciences — Hekaiwei is a provider of innovative solutions for women's health.

Yuanhe Holding

Investment focus

Manufacturing, Biotechnology, Artificial Intelligence
Series A, Series B, Seed
China

Portfolio highlights

Ruijiewei — Ruijiewei is a high-end integrated circuit packaging and testing service provider. They have hundreds of chip packaging project management and delivery experience, with a focus on the design of sophisticated chip packaging solutions, large-scale packaging processing, and production, and completed product testing. Ruijiewei is dedicated to theadvancement of domestic industry cooperation.
Banyan Photonics — Banyan Photonics is an optical communication chip design and manufacturer of materials to develop and construct photonic integration.
Panomic Biomedical Technology — Suzhou Panomic Biomedical Technology Co., Ltd. (BioNovoGene) was founded in Suzhou Industrial Park Bio-Nano Park in 2013. It is a leading high-tech enterprise focusing on metabolomics in China. Since its establishment, it has established a complete metabolomics detection and analysis platform - PanomicTM / Bionovogene, including metabolitepreprocessing platform, high-resolution mass spectrometry analysis platform, and metabolomics data analysis with independent intellectual property rights The system has perfect biomarker discovery capabilities and clinical application capabilities. The company's scientific research team has a rich background, covering biochemistry, bioinformatics, epidemiology and biostatistics, computer science, etc., and has a consultant team composed of top scientists and clinicians.

N5Capital is a Beijing-based leading venture capital firm focusing on early stage investment in mobile internet. N5Capital is the only early stage USD venture fund in China specializing in mobile internet, big data and cloud’s disruptive convergence with consumer sectors. N5 believes these technologies are emerging to be the infrastructure ofproductivity growth and consumer behavior transformation. Founded in 2013 by Mr. Will Jiang and Mr. Weiguo Zhao, N5Capital is currently managing two RMB funds and one USD fund, with the total capital managed at $350 million USD. In 2016, N5Captial was awarded the Top 20 Early Stage Venture Capital Firm in China. The power of mobile disruption in the internet savvy Chinese population guarantees a strong investment potential. With more than 60 companies in its portfolio, N5Capital has represented some of the most leading-edge tech companies, including Talking Data, 360 Finance, Car 300, Hot & Hot, Viva Video, LGD, Ofashion and inMotion/SoloWheel. N5Capital has a unique GP team combination with a collective successful track record spanning from angel, early stage, and growth stage to corporate M&A with approximately 30 years combined investment experience. N5Capital analyzes in consumer sectors such as finance, retail, housing, automobile, travel among others and invests in start-ups that thrives on either build or leverage the underlying technology to disrupt or recreate the industry value chain . Through an expansive network, in-depth industry analysis and rigorous user behavior research, N5Capital is shifting the investment landscape for both start-ups and investors. For more information, visit www.n5capital.com.

Investment focus

E-Commerce, Internet, Gaming
Series A, Seed, Series B
China, United States, India

Portfolio highlights

Feiyu — Feiyu is an online purchasing platform for luxury trading bags.
Harmay — HARMAY is based on contemporary fashion and aesthetics, conveys the concept of beauty and beautiful life. Covering first well-known international cosmetics and skin care brands products, global unique boutiques, and HARMAY’s own products,
Zhongying Cross-border — Zhongying Cross-border is a cross-border e-commerce comprehensive service platform.

Hefei Industry Investment Group is an industrial investment and financing company.

Investment focus

Manufacturing, Semiconductor, Electronics
Series A, Series B, Funding Round
China, Israel

Portfolio highlights

Inuchip — Yinniu Microelectronics offers a high-tech enterpris in 3D binocular stereo vision and multi-sensor fusion visual processing + artificial intelligence chips and product design.
Puli Materials — Puli Materials is a high-tech company that involves research, development, and manufacturing of carbon dioxide-based novel materials.
Kecheng Intelligent Health — Kecheng Intelligent Health China University of Science and Technology empowers biopharmaceutical companies. It has currently established a multi-omics detection and data storage platform, reshaping immune cell and stem cell platform, and a reshaping immune cell and stem cell platform, relying on cutting-edge technologies such as new generationartificial intelligence and quantum information technology, focusing on industrial needs and creating a new track for innovative R&D-based on multi-omics.

Boyu Capital Consultancy Co. Ltd is a private equity firm specializing in investments in China. Boyu Capital Consultancy Co. Ltd was founded on September 28, 2010 and is based in Hong Kong with an additional office in Beijing, China.

Investment focus

Biotechnology, Health Care, Pharmaceutical
Series A, Series C, Series D
China, United States, Hong Kong

Portfolio highlights

Doujin Culture — Doujin Culture is a cross-border e-commerce firm offers significant support for brands looking to expand internationally.
ArriVent Biopharma — Leveraging Global Discoveries, Arrivent Biopharma is Building a Unique Handpicked Pipeline GroundedIn Innovative Science
Tianbing Technology — Tianbing Technology is an advanced aerospace propulsion system supplier and aerospace vehicle provider. Tianbing Technology independently develops the next-generation ambient temperature green HCP liquid propellant and minimalist aerospace propulsion system. As an upgraded product of traditional chemical propulsion system, it can meetcost-effective aerospace. Advance system supporting needs. The next-generation green HCP aerospace propulsion system, first tested by Tianbing Technology, can be used in the small-vehicle main power and launch vehicle upper-level propulsion system.

Kanghua Biological is a research and development, production, and operation of preventive biological products.The company's research and development, production base, SPF laboratory animal center, and high-tech bacterial and virus vaccine GMP production workshop occupy 30,000 square meters. Its existing product includes ACYW135 groupMeningococcal Polysaccharide Vaccine, (trade name: Maicred) and Freeze-dried Rabies Vaccine for Human Use (Human Diploid Cells), (trade name: HDCV). It has been awarded the titles of "Postdoctoral Innovation Practice Base", "Sichuan Province Constructive Innovation Enterprise Cultivation Enterprise", "Sichuan Province Excellent Integrity Demonstration Unit" by the Personnel Department and the Science and Technology Department.It was founded in 2004 in Chengdu, Sichuan, China.

Investment focus

Genetics, Biotechnology, AgTech
Series A, Series C
China

Portfolio highlights

Igenesis — Igenesis is a biotechnology company that provides molecular diagnostic technologies.
HC Scientific — HC Scientific is a high-tech enterprise integrating research, development, production and sales of a new biomedical system
Abogen Biosciences — Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics for treatment of cancer and infectious diseases.

Zhengxuan Investment is an investment institution that develops high-tech and innovative enterprises. It is focused in advanced manufacturing, artificial intelligence, robotics, new energy, new materials, semiconductor, aerospace, and other fields. It also focuses on the investment and development of Chinese national enterprises, creatingemployment opportunities, creating government tax revenues, benefit the society, and cultivating a group of innovative enterprises and entrepreneurs. It offers a win-win situation for the benefit sharing and win-win situation for the company's shareholders, employees, partners, and invested companies. The company has Zhengxuan Qianhai Fund, Zhengxuan Foresight Fund, Zhengxuan Venture Capital, Zhengxuan Chuangke Space, Di Chuanghui, and other subjects.Zhengxuan Investment was founded in June 2003 and is headquartered in Shenzhen, China.

Investment focus

Software, Manufacturing, Information Technology
Series A, Angel, Seed
China

Portfolio highlights

Botai Automation — Botai Automation is specialized in CNC system research and development. Its CNC system can be used in machine tools, including drilling and tapping machines, turning and milling compound machining centers and their control accuracy, stability, and performance outperform earlier products of the same type.
First Automation — First Automation is an autonomous and controllable general-purpose high-end CNC system research and development company.
Xihua Technology — Xihua Technology is a supplier of ultra-precision cutting and grinding diamond tools and equipment.

NewMargin Ventures is a Chinese venture capital management company that supports emerging entrepreneurs.Founded in July 1999, NewMargin Ventures offers a unique and compelling combination of strong local and national government support within an organizational culture defined by independent decision-making, professionalism, and teamwork.NewMargin currently has about $520 million under management.

Investment focus

Information Technology, Manufacturing, Internet
Series A, Angel, Series B
China, United States, Hong Kong

Portfolio highlights

Humi.com — Humi.com is an industrial Internet service platform.
Shexu Technology — Established in 2020, Shanghai Shexu Technology Co., Ltd. is an AI-driven industrial design software R&D technology enterprise and design service provider. The company has a professional scientific research and technical team, and has independently developed automatic industrial design software based on AI computing engine. The design softwarehas been widely used in the field of automotive industry equipment, significantly improving the design efficiency of industrial machinery designers.
Vkansee Technology — VKANSEE is ushering in a new age of mobile security with its revolutionary, patented new breed of UTFiS fingerprint sensors. Our fingerprint capture and matching technology enables mobile security for payment applications, data storage, access control and more. They're headquartered in Beijing, with an R&D office in Shenzhen and sales/ support offices in New York City.

Sunz Fund is a venture capital firm that focuses on investments in life science, medical health and resources environment sectors.

Investment focus

Medical, Health Care, Biotechnology
Series A, Series B, Seed
China

Portfolio highlights

Treat Gut — Treat Gut provides a comprehensive solution for precise bacterial transplantation treatment.
Yingsheng Biology — Yingsheng Biotechnology Co., Ltd. (referred to as Yingsheng Bio) was established in 2009, and is committed to the application of molecular diagnostic techniques such as maternal and child health, neonatal genetic diseases, metabolic diseases, birth defects and other human genetics, and national eugenics engineering. Yingsheng's product lineincludes 45 innovative genetic metabolic disease screening reagents, 14 vitamins determination reagents, mass spectrometer automatic intelligent processing platform, and ultra-high performance liquid chromatography tandem mass spectrometry detection system. level.
AccuMed Technology — Shanghai AccuMed Technology Ltd. (R&D HQ) is an advanced medical technology development company who specializes in developing new technologies and manufacturing intelligent medical devices for precise surgical operation. The team consists of scientists and senior medical professionals to make this reality. The R&D HQ is located in theNeobay Global Innovation Base in Minhang District, Shanghai; and the manufacturing division (Nantong AccuMed Technology Ltd.) is located in Maipu Scientific Park in Chongchuan District, Nantong, Jiangsu. To support the development of minimally invasive and accurate clinical practices and fulfill the increasing clinical demand, AccuMed pays special attentions to develop a low-cost and highly-accurate surgical navigation system for total solutions on surgical and interventional therapy. AccuMed relies on the scientific research provided by the research lab of the School of Biomedical Engineering in Shanghai Jiao Tong University in order to maintain leading clinical advancements. Our world-leading research team can also perform seamless translational research. Relying on the matured and optimized business mode, we continue to contend for a better and more precise products.

Hongfeng Investment Management is an investment firm.

Investment focus

Biotechnology, Health Care, Medical
Series A, Seed, Angel
China

Portfolio highlights

Leadopharma — Leadopharma engages in the research and development of drugs targeting pain, epilepsy, depression, and neurodegenerative diseases. Leadopharma has established a complete pharmaceutical chemistry and ion channel drug research and development platform and team, which can independently carry out drug synthesis, activity screening, and early safetypharmacology research for ion channel targets.
Jianxin Biotech — Jianxin Bio focuses on new monoclonal antibody drugs, CAR-T (Chimeric Antigen Receptor T Cell) technology innovation.
Zilixir Biotech — Zilixir Biotech develops a new protein design technology that offers possibilities for human exploration of the complex life sciences. SWORD™ protein design technology integrates binding pockets, new drug skeleton design, activity prediction, ADME/T prediction, etc., and has had some achievements in these areas, fully demonstrating theeffectiveness of protein design.

Wanwu Capital is an investment firm

Investment focus

Artificial Intelligence, Agriculture, SaaS
Series A, Funding Round, Seed
China

Portfolio highlights

Mogic AI — Mogic AI is an advertising technology platform that provides tools to create and launch campaigns by pulling product images into ads using AI.
Huida Tech — Heilongjiang Huida Technology Development Co., Ltd. is a developer of agricultural machinery operation detection equipment. It focuses on the combination of Internet technology and smart agriculture, and provides agricultural production efficiency and management level through information technology. It is a leading domestic agricultural machineryinformatization solution. provider.
Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.

Zhejiang Synergy is an investment company.

Investment focus

Life Science, Biotechnology
Series A
China

Portfolio highlights

Derlead — Derlead is a biotechnology company that develops vitro diagnostic reagent products.

By adopting revolutionary mechanisms, FREES FUND is devoted to change the long-established rules in the venture capital. By leveraging the cutting-edge technologies and resources, FREES FUND aims at investing in great startups and helping them grow into great enterprises that are valuable to our society. We mainly invest in early-stagestartups, and hope to become their first-round institutional investor. Our primary interested areas are broad-sense TMT (Technology, Media, Telecom), B2B and deep technology.

Investment focus

Artificial Intelligence, Biotechnology, Medical
Series A, Seed, Angel
China, United States, Singapore

Portfolio highlights

Aeroband — Aeroband is a manufacturer of air paddles and other musical instruments.
Brix — Brix is an AI-based platform that offers online recruiting services and solutions.
Babel AI — Babel AI offers users full-process AI services for software development, operation, and maintenance. Its objective is to increase software development efficiency by recreating automated and visible AI-generated software workflows and software operating environments.

Yingmeng Capital is an investment firm.

Investment focus

Life Science, Biotechnology
Angel
China

Portfolio highlights

Zevi Bio — Zevi Bio is a tumor in situ target capture technology platform.

Nanjing Fuze is an investment company.

Investment focus

Life Science, Biotechnology
Angel
China

Portfolio highlights

Zevi Bio — Zevi Bio is a tumor in situ target capture technology platform.

Alibaba Group’s mission is to make it easy to do business anywhere. They enable businesses to transform the way they market, sell, operate, and improve their efficiencies. They provide the technology infrastructure and marketing reach to help merchants, brands, and other businesses to leverage the power of new technology to engage with theirusers and customers and operate in a more efficient way.Their businesses are comprised of core commerce, cloud computing, digital media and entertainment, and innovation initiatives. In addition, Ant Financial, a company in which they have agreed to acquire a 33% equity stake, provides payment and financial services to consumers and merchants on their platforms. An ecosystem has developed around their platforms and businesses that consists of consumers, merchants, brands, retailers, other businesses, third-party service providers, and strategic alliance partners.

Investment focus

E-Commerce, Software, Internet
Series B, Series A, Series C
China, United States, India

Portfolio highlights

Xreal — Nreal is the developer of ready-to-wear mixed reality glasses. Its flagship product, Nreal light, is the first lightweight and comfortable mixed reality glasses, sporting a vivid display combined with spatial computing algorithms for an immersive experience. The company aims to make mixed reality available and accessible to everyone. They strive torealize the full potential of mixed reality by empowering developers to create applications that can ultimately propel a new era of entertainment, productivity, and more.Nreal was founded in 2017 and is based in Beijing, China.
MiniMax — MiniMax develops artificial intelligence technology for social connections and interaction, converting text into visual, audio, and text to text modes for free chat and plot tasks.
Moonshot AI — Dark Side of the Moon is an AI large-scale model company.

Shengshan Capital is an investment firm.

Investment focus

Biotechnology, AgTech, Genetics
Series A
China

Portfolio highlights

Tekeluo Biotech — Tekeluo Biotech is a Healthcare company.
Changjin Biotechnology — Changjin Biotechnology engages in the research, development, and industrialization of microbial synthetic proteins.

KAITAI CAPITAL, founded in 2009, is a professional investment management organization that mainly engaged in innovative investment, industrial investment, and wealth management business. Fields of investment include biopharma, healthcare services, agriculture tech, consumer business, digital technology and etc.

Investment focus

Biotechnology, Health Care, Pharmaceutical
Series A, Angel, Seed
China, United States

Portfolio highlights

Chiplego — Chiplego focuses on embedded high-performance computing systems that assist in the creation of a mobile digital world and a better travel and life experience for everyone.
Levinthal — Levinthal is an AI-driven protein design platform. They offer services for artificial intelligence in food safety and medical care. They offer synthetic biology, food, feed, and environmental protection.
Huaboron Neutron — Huaboron Neutron is a biotechnology company that develops boron drugs and boron neutron capture therapy devices for the diagnosis of malignant cancers.

Gong Hongjia

Investment focus

Audio, Music, Computer
Seed, Angel, Series C
China

Portfolio highlights

KMAX — KMAX specializes in AR and VR content research and development. It has independently developed core technologies such as real-time 3D modeling, 3D generalized cloud connection, cloud VR resource rendering, and an editing engine.
POROSVOC — POROSVOC is an audio processing technology company that offers chip-level core services for intelligent voice enhancement and intelligent voice interaction solutions for financial equipment, communication equipment, robots, smart home products, small household appliances, and other industries.
CapitalBio Pharma — CapitalBio Pharma is a biotechnology company that specializes in innovative medicines to empower precise diagnosis and treatment. It is a subsidiary of CapitalBio Corporation.

Investors by industry

Media (entertainment)

EdTech

Consumer

Climate